CRV Closes $750M CRV XX, Refocuses on Early Stage
CRV closed its twentieth flagship fund, CRV XX, at $750M in four weeks, doubling down on early-stage investing and stepping back from late-stage Select funds.
The Blog
A statically generated blog example with news, tutorials, resources and other interesting content related to AstroWind
-
-
July 2025 NYC VC Fund Roundup: Boldstart $250M, Betaworks $66M, and 49 Global Fund Closes
July 2025 brought Boldstart's $250M Fund VII, Betaworks' $66M AI fund, and Verified Capital's $175M debut — plus $6.77B in global new VC dry powder.
-
July 2025 Life Sciences Mega Close: Frazier Life Sciences Closes $1.3B Fund XII
Frazier Life Sciences closed Fund XII at over $1.3 billion on July 31, 2025 — one of the largest biotech venture funds closed in July 2025.
-
July 2025 Growth Equity Close: Glade Brook Raises $515M Fund IV
Greenwich and Miami-based Glade Brook Capital closed Strategic Growth Fund IV at $515 million on July 22, 2025, targeting FinTech, AI, SpaceTech, and DefenseTech growth equity.
-
NYC VC Fund Launch: Betaworks Closes $66M Fund III for Early-Stage AI
New York City-based Betaworks announced the $66M close of Fund III on July 22, 2025, continuing its legacy of backing creative technologists building AI-native products.
-
July 2025 VC Fund Close: Modi Ventures Closes $88M Fund II for Tech-Bio Convergence
Houston-based Modi Ventures closed its oversubscribed second fund at $88 million on July 16, 2025, investing at the intersection of AI, biology, and medical technology.